About Kestra Medical Technologies
Kestra Medical Technologies is a company based in Kirkland (United States) founded in 2014. Kestra Medical Technologies has raised $196 million across 2 funding rounds from investors including Bain Capital, T. Rowe Price and Andera Partners. The company has 330 employees as of April 30, 2024. Kestra Medical Technologies offers products and services including ASSURE System, Kestra CareStation, and ASSURE Patient Application. Kestra Medical Technologies operates in a competitive market with competitors including AtaCor Medical, CardioFocus, AtriCure, TyRx and EBAMed, among others.
- Headquarter Kirkland, United States
- Employees 330 as on 30 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kestra Medical Technologies, Ltd.
-
Annual Revenue
$59.81 M (USD)115.05as on Apr 30, 2025
-
Net Profit
-$113.81 M (USD)-20.92as on Apr 30, 2025
-
EBITDA
-$98.41 M (USD)-33.89as on Apr 30, 2025
-
Total Equity Funding
$196 M (USD)
in 2 rounds
-
Latest Funding Round
$196 M (USD), Series B
Jul 24, 2024
-
Investors
Bain Capital
& 9 more
-
Employee Count
330
as on Apr 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Kestra Medical Technologies
Kestra Medical Technologies is a publicly listed company on the NASDAQ with ticker symbol KMTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Kestra Medical Technologies
Kestra Medical Technologies offers a comprehensive portfolio of products and services, including ASSURE System, Kestra CareStation, and ASSURE Patient Application.
Wearable defibrillator for monitoring and treating cardiac arrhythmias.
Platform for managing at-risk cardiac patient data remotely.
App to engage patients in their cardiac recovery and monitoring.
People of Kestra Medical Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Kestra Medical Technologies
Kestra Medical Technologies has successfully raised a total of $196M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $196 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kestra Medical Technologies
Kestra Medical Technologies has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bain Capital, T. Rowe Price and Andera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
Private equity firm focused on life science sector
|
Locked | Locked | Locked |
Investor details for Kestra Medical Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kestra Medical Technologies
Investment portfolio details for Kestra Medical Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kestra Medical Technologies
Detailed financials for Kestra Medical Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kestra Medical Technologies Comparisons
Peer comparison for Kestra Medical Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kestra Medical Technologies
Kestra Medical Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, CardioFocus, AtriCure, TyRx and EBAMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Antibacterial envelopes are developed for stabilizing cardiac implantable devices.
|
|
| Locked | Locked | Locked |
Non-invasive treatments for cardiac arrhythmias are developed by EBAMed.
|
Detailed competitors of Kestra Medical Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kestra Medical Technologies
Complete news archive for Kestra Medical Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kestra Medical Technologies
Kestra Medical Technologies was founded in 2014.
Kestra Medical Technologies is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.
Brian Webster is the current CEO of Kestra Medical Technologies.
Kestra Medical Technologies is a funded company, having raised a total of $196M across 2 funding rounds to date.
As of Apr 30, 2024, the latest employee count at Kestra Medical Technologies is 330.
Annual revenue of Kestra Medical Technologies is $59.81M as on Apr 30, 2025.
Kestra Medical Technologies was founded in 2014 and is based in Kirkland, United States. Operations center on the medical technology sector, where external defibrillation systems, implantable cardiac rhythm management devices, and class III medical devices are developed to aid patients vulnerable to cardiovascular conditions. Collaborations are pursued with entities specializing in consumer wearables, wireless solutions, and therapeutic class III devices.
Kestra Medical Technologies's top competitors include AtaCor Medical, AtriCure and CardioFocus.
Kestra Medical Technologies offers ASSURE System, Kestra CareStation, and ASSURE Patient Application.
Yes, Kestra Medical Technologies is publicly traded on NASDAQ under the ticker symbol KMTS.
Kestra Medical Technologies has 10 investors. Key investors include Bain Capital, T. Rowe Price, Andera Partners, Ally Bridge Group, and Longitude Capital.
The ticker symbol of Kestra Medical Technologies is KMTS on NASDAQ.